Eva D. Papadimitraki

Expansion of toll‐like receptor 9–expressing B cells in active systemic lupus erythematosus: Implications for the induction and maintenance of the autoimmune process

Eva D. Papadimitraki, Christianna Choulaki, Eleni Koutala et al. · Arthritis & Rheumatism · 2006 · 185 citations

Life Sciences, Immunology, Pathobiology +17

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

Magda Nakou, Georgios Katsikas, Prodromos Sidiropoulos et al. · Arthritis Research & Therapy · 2009 · 133 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus

George Βertsias, Magda Nakou, Christianna Choulaki et al. · Arthritis & Rheumatism · 2008 · 109 citations

Life Sciences, Immunology, Molecular Genetics +17

Childhood- and adult-onset lupus: an update of similarities and differences

Eva D. Papadimitraki, David Isenberg · Expert Review of Clinical Immunology · 2009 · 108 citations

Life Sciences, Immunology, Pediatrics +12

Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.

Eva D. Papadimitraki, George Βertsias, Christianna Choulaki et al. · PubMed · 2013 · 83 citations

Life Sciences, Cell Biology, Immunology +17